Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3a,Condition 3b 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",eye electrophysiology trait,,RS:0000660,RCS/LavRrrc,both,0 days,5,,CMO:0003656,b-wave amplitude of ERG waveform,,scotopic b-wave ERG,,137,uV,18.0,40.2492,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,60,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd/m2) ",108664,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (2.5 cd/m2) , 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",rod electrophysiology trait,,RS:0000698,Hsd:SD,both,0 days,9,,CMO:0003705,scotopic B wave amplitude of ERG waveform,,scotopic b-wave ERG,,387,uV,,,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,30,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2) ",108646,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (5 cd/m2) , 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",rod electrophysiology trait,,RS:0000698,Hsd:SD,both,0 days,9,,CMO:0003705,scotopic B wave amplitude of ERG waveform,,scotopic b-wave ERG,,397,uV,,,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,30,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2) ",108652,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (5 cd/m2) , 3129,"Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.",rod electrophysiology trait,,RS:0000652,RCS/N,not specified,62 days,6,,CMO:0003705,scotopic B wave amplitude of ERG waveform,,scotopic b-wave amplitude ERG,,500,uV,61.2372,150.0,MMO:0000616,electroretinography,cornea,0.0,treated eye,AAV8 injection,60,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) ",108682,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (2.5 cd x s/m2) , 3129,"Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.",rod electrophysiology trait,,RS:0000652,RCS/N,not specified,242 days,4,,CMO:0003705,scotopic B wave amplitude of ERG waveform,,scotopic b-wave amplitude ERG,,223,uV,28.0,56.0,MMO:0000616,electroretinography,cornea,0.0,treated eye,AAV8 injection,240,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.01 cd x s/m2) ",108684,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (0.01 cd x s/m2) , 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",rod electrophysiology trait,,RS:0000698,Hsd:SD,both,0 days,9,,CMO:0003706,scotopic A wave amplitude of ERG waveform,,scotopic a-wave ERG,,154,uV,,,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,30,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2) ",108648,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (5 cd/m2) , 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",rod electrophysiology trait,,RS:0000698,Hsd:SD,both,0 days,9,,CMO:0003706,scotopic A wave amplitude of ERG waveform,,scotopic a-wave ERG,,173,uV,,,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,30,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (5 cd/m2) ",108654,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (5 cd/m2) , 3129,"Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.",rod electrophysiology trait,,RS:0000652,RCS/N,not specified,62 days,6,,CMO:0003706,scotopic A wave amplitude of ERG waveform,,scotopic a-wave amplitude ERG,,175,uV,14.6969,36.0,MMO:0000616,electroretinography,cornea,0.0,treated eye,AAV8 injection,60,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) ",108680,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) ",controlled exposure to darkness (for 12 hours),visible light stimulus (2.5 cd x s/m2) , 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",cone electrophysiology trait,,RS:0000698,Hsd:SD,both,0 days,9,,CMO:0003702,photopic B wave amplitude of ERG waveform,,photopic b-wave ERG,,59,uV,,,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,30,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) then controlled visible light condition (30 cd x s/m2) then visible light stimulus (12 cd/m2) ",108650,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (4 x 10E8 vg) ",controlled visible light condition (30 cd x s/m2) ,visible light stimulus (12 cd/m2) , 3128,"Conlon TJ, et al., Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3.",cone electrophysiology trait,,RS:0000698,Hsd:SD,both,0 days,9,,CMO:0003702,photopic B wave amplitude of ERG waveform,,photopic b-wave ERG,,57,uV,,,MMO:0000616,electroretinography,cornea,0.0,,subretinal injection,30,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) then controlled visible light condition (30 cd x s/m2) then visible light stimulus (12 cd/m2) ",108656,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (40 x 10E8 vg) ",controlled visible light condition (30 cd x s/m2) ,visible light stimulus (12 cd/m2) , 3129,"Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831.",cone electrophysiology trait,,RS:0000652,RCS/N,not specified,242 days,4,,CMO:0003702,photopic B wave amplitude of ERG waveform,,photopic b-wave amplitude ERG,,30,uV,5.5,11.0,MMO:0000616,electroretinography,cornea,0.0,treated eye,AAV8 injection,240,days,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) then controlled visible light condition (30 cd/m2) (for 0.1 hours) then visible light stimulus (10 cd x s/m2) and controlled visible light condition (30 cd/m2) ",108685,"gene transfer of the rat MER proto-oncogene, tyrosine kinase gene using an adenovirus vector (21.6 x 10E8 vg) ",controlled visible light condition (30 cd/m2) (for 0.1 hours),visible light stimulus (10 cd x s/m2) ,controlled visible light condition (30 cd/m2)